Simplify Propel Opportunities ETF (SURI)
17.90
0.00 (0.00%)
USD |
NYSEARCA |
Dec 05, 16:00
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 2.50% | 1.61% | 80.05M | 2886.20 |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 0.00% | 22.00% | -12.15M | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term capital appreciation. The Fund concentrates its investments in the securities of issuers in the biotechnology pharmaceuticals healthcare technology and life science tools and services industries. The Fund invests without restriction as to security currency issuer capitalization. |
| General | |
| Security Type | Exchange-Traded Fund |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | Simplify |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of December 06, 2025.
Asset Allocation
As of October 31, 2025.
| Type | % Net |
|---|---|
| Cash | 0.44% |
| Stock | 69.56% |
| Bond | 3.41% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 26.59% |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term capital appreciation. The Fund concentrates its investments in the securities of issuers in the biotechnology pharmaceuticals healthcare technology and life science tools and services industries. The Fund invests without restriction as to security currency issuer capitalization. |
| General | |
| Security Type | Exchange-Traded Fund |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | Simplify |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |